Drug Affordability Review Board Legislation

NASHP’s prescription drug affordability review board legislation enables states to set allowable rates for certain high-cost drugs, similar to the process states use to regulate utilities or insurance premiums. Under this law, a state drug affordability review board would establish the maximum amount that payers would pay for individual drugs. While transparency laws expose the true cost of drugs, this approach takes the next step to protect consumers and payers from over-priced drugs.

Model Affordability Review Board (Rate-Setting) Legislation
Model Legislation Explanation
Drug Affordability Review Board Legislation Q&A
Drug Affordability Review Boards (Rate Setting) Explained – Blog
Comparison Chart of States’ Affordability Review Board Bills

NASHP works with states to advance drug affordability review board legislation and will continue to track and report on those efforts at its Center for State Rx Drug Pricing.  Contact Jennifer Reck for more information.

Latest Resources